- Company uses strategic agreements, acquisitions, and intellectual property to achieve multiple growing verticals within global cannabis industry
- U.S. hemp industry has seen massive growth since 2018 Farm Bill legalized industrial hemp
- Experts predict CBD sector will reach $20 billion in 2024
MCTC Holdings Inc. (OTC: MCTC), a cannabinoid science innovator (dba Cannabis Global), is positioned at the cutting edge of the industry’s trends with its focus on polymeric nanotechnology designed to maximize bioavailability. The company plans to market and license multiple polymeric cannabinoid nanoparticle and nanofiber-based products that will offer enhanced bioavailability and release properties as well as advanced customization options. As polymer-based particles offer significant loading of active ingredients and increased flexibility and customization, MCTC believes this will allow for multiple cannabinoid combinations with unique features.
Recently, the company filed six patents (all six patents are pending approval with USPTO), of which its fourth cannabinoid delivery technology patent is the most important for cannabinoid delivery systems. This patent broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium (http://cnw.fm/NsK5S).
The company’s sixth patent also pertains to delivery systems — it is for a unique dosing system that makes it possible for any manufacturer of coffee pods to add cannabinoids or other active ingredients to coffee pods with ease.
“The patent filing broadly outlines a variety of methods and technologies to be used for adding cannabinoids to single-serving coffee pods. With our system, any manufacturer of coffee pods can now produce CBD or other coffee pods with simple modification to their processes. The patent filing represents growth of our intellectual property to include broader systems for cannabinoid delivery,” MCTC CEO Arman Tabatabaei stated in a news release (http://cnw.fm/eDh95).
Through 2020, the company plans to conduct trials on exotic and lesser-known cannabinoids like cannabinol (CBN) and THC-V, including their potential effects on appetite suppression. MCTC is also working with patent counsel to protect various other aspects of its other new technologies. The company has announced a new research project named THC-V Skinny Cannabinoid Project Varin for THC-V infusions, nanoparticles, and glycosides.
The company’s flagship beverage product line, Hemp You Can Feel(TM) is an organic, ultra-clean label line of CBD powdered drink and hemp extract mixes, including soft beverages and non-alcoholic cocktail mixers. It is carefully manufactured via a closely monitored production process from start to finish. The green coffee beans are imported, roasted, and ground on site. The product is infused with only hemp extracts, honey from organic farms, organic non-GMO starches from vegetables, and trace amounts of organic vegetable and coconut oils, a fact reflected in the price and quality of their products. The manufacturing method used is an innovative two-stage hemp extract infusion process currently Patent Pending with the U.S Patent and Trademark Office.
Hemp You Can Feel(TM) is 100% compostable within 120 days of being discarded properly. This includes the packaging, the lid, the coffee pod, and the package inserts. Each coffee pod contains at least 30 milligrams of CBD, a large number of additional hemp extract components, and no detectable THC (http://cnw.fm/c5oTX).
MCTC recently signed a distribution contract with Marijuana Company of America (OCTQB: MCOA) for the Hemp You Can Feel(TM) beverage product line and plans to extend the collaboration to other drink offerings to be introduced soon (http://cnw.fm/opM0B). As MCOA specializes in delivering renowned brands through distributors and unique marketing strategies, the agreement is expected to bring added visibility to MCTC’s products.
As an integrated cannabis business operation and cannabinoid science innovator, MCTC Holdings is primarily focused on high-growth and high-margin sub-sectors of the cannabis and hemp industry, including multiple growing verticals in the global cannabis and industrial hemp markets via acquisitions, partnerships and the development of new intellectual property.
The U.S. hemp industry has seen massive growth since the 2018 Farm Bill legalized the cultivation of industrial hemp. The sector was worth millions just a year after federal legalization, augmented by the demand for hemp-derived CBD. According to research from BDS Analytics and Arcview Market Research, the U.S. CBD market is expected to reach $20 billion in sales by 2024 (http://cnw.fm/8kIqV). Meanwhile, the global industrial hemp market is poised to grow exponentially as well — from $4.6 billion in 2019 to $26.6 billion by 2025, recording a CAGR of 34%, as indicated by a Research and Markets report (http://cnw.fm/vCiG7).
For more information, visit the company’s website at www.CannabisGlobalInc.com
NOTE TO INVESTORS: The latest news and updates relating to MCTC are available in the company’s newsroom at http://cnw.fm/MCTC
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com
CBDWire is part of the InvestorBrandNetwork.